Rhumbline Advisers raised its holdings in Varex Imaging (NASDAQ:VREX) by 2.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 76,119 shares of the company’s stock after acquiring an additional 1,860 shares during the period. Rhumbline Advisers owned 0.20% of Varex Imaging worth $2,576,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Security National Trust Co. acquired a new position in Varex Imaging in the 2nd quarter valued at $108,000. Ameritas Investment Partners Inc. acquired a new position in Varex Imaging in the 2nd quarter valued at $112,000. Howard Hughes Medical Institute acquired a new position in Varex Imaging in the 2nd quarter valued at $134,000. Oppenheimer Asset Management Inc. acquired a new position in Varex Imaging in the 2nd quarter valued at $136,000. Finally, Pinebridge Investments L.P. purchased a new stake in shares of Varex Imaging during the 2nd quarter valued at $167,000. Institutional investors own 92.79% of the company’s stock.

Shares of Varex Imaging (NASDAQ VREX) opened at $37.55 on Monday. The company has a debt-to-equity ratio of 1.22, a current ratio of 3.26 and a quick ratio of 1.72. Varex Imaging has a 12-month low of $25.00 and a 12-month high of $38.80.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings results on Thursday, November 9th. The company reported $0.59 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.07. The business had revenue of $216.00 million for the quarter, compared to analysts’ expectations of $213.73 million. The firm’s revenue for the quarter was up 25.5% on a year-over-year basis. equities research analysts expect that Varex Imaging will post 1.82 earnings per share for the current fiscal year.

In related news, insider Sunny Sanyal sold 50,000 shares of the company’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $36.50, for a total transaction of $1,825,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Several brokerages have recently issued reports on VREX. Zacks Investment Research cut shares of Varex Imaging from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th. J P Morgan Chase & Co cut shares of Varex Imaging from a “neutral” rating to an “underweight” rating and set a $33.00 price objective for the company. in a research note on Wednesday, October 4th. Finally, Jefferies Group boosted their price objective on shares of Varex Imaging to $39.00 and gave the company a “buy” rating in a research note on Friday, November 10th.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Watch List News and is the property of of Watch List News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.watchlistnews.com/rhumbline-advisers-has-2-58-million-holdings-in-varex-imaging-vrex/1757005.html.

Varex Imaging Company Profile

Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect.

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.